The behavioral pharmacology of zolpidem: Evidence for the functional significance of α1-containing GABAA receptors

Psychopharmacology

Volumn 231, Issue 9, 2014, Pages 1865-1896

  Fitzgerald, Amanda C ^a   Wright, Brittany T ^a   Heldt, Scott A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Anticonvulsant; Anxiety; Benzodiazepine; EEG; Food intake; GABA receptor; Hypothermia; Learning and memory; Motor activity; Reward

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; ESZOPICLONE; ISONIAZID; PENTETRAZOLE; ZOLPIDEM; ZOPICLONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; PYRIDINE DERIVATIVE;

ANTICONVULSANT ACTIVITY; ANXIETY; BASAL BODY TEMPERATURE; COMPARATIVE STUDY; CROSS TOLERANCE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERANCE; ELECTRIC SHOCK; ELECTROENCEPHALOGRAM; EXPERIMENTAL SEIZURE; EXPLORATORY BEHAVIOR; FLUID INTAKE; FOOD INTAKE; HUMAN; HYPERTHERMIA; LEARNING; LOCOMOTION; MEMORY; MEMORY DISORDER; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PUNISHMENT; REINFORCEMENT; REVIEW; SLEEP WAKING CYCLE; STRESS; WITHDRAWAL SYNDROME; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; GABA-A RECEPTOR AGONISTS; HUMANS; PYRIDINES; RECEPTORS, GABA-A;

EID: 84899628168     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3457-x     Document Type: Review

References (290)

1. Adams R, Victor M (1993) Principles of neurology (5th ed.; Lamsback WJ and Navrozov M, eds). McGraw-Hill, New York
2. Alexandre C, Dordal A, Aixendri R, Guzman A, Hamon M, Adrien J (2008) Sleep-stabilizing effects of E-6199, compared to zopiclone, zolpidem and THIP in mice. Sleep 31:259-70
3. André V, Pineau N, Motte JE, Marescaux C, Nehlig A (1998) Mapping of neuronal networks underlying generalized seizures induced by increasing doses of pentylenetetrazol in the immature and adult rat: a c-Fos immunohistochemical study. Eur J Neurosci 10:2094-2106
4. Aragona M (2000) Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report. Clin Neuropharmacol 23:281-3
5. Ator NA (1999) High-dose discrimination training with midazolam: context determines generalization profile. Pharmacol Biochem Behav 64:237-43
6. Ator NA (2002) Relation between discriminative and reinforcing effects of midazolam, pentobarbital, chlordiazepoxide, zolpidem, and imidazenil in baboons. Psychopharmacol (Berl) 163:477-87
7. Ator NA (2003) Selectivity in generalization to GABAergic drugs in midazolam-trained baboons. Pharmacol Biochem Behav 75:435-45
8. Ator NA (2005) Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders. CNS Spectr 10:31-9
9. Ator NA, Griffiths RR (2003) Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend 70:S55-S72
10. Ator NA, Weerts EM, Kaminski BJ, Kautz MA, Griffiths RR (2000) Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. Drug Alcohol Depend 61:69-84
11. Backus KH, Arigoni M, Drescher U, Scheurer L, Malherbe P, Mohler H, Benson JA (1993) Stoichiometry of a recombinant GABAA receptor deduced from mutation-induced rectification. Neuroreport 5:285-8
12. Bailey L, Ward M, Musa MN (1994) Clinical pharmacokinetics of benzodiazipines. J Clin Pharmacol 34:804-811
13. Bailey JE, Papadopoulos A, Seddon K, Nutt DJ (2009) A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety. J Psychopharmacol 23:117-22
14. Bammer G (1982) Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: a review and some new results. Neurosci Biobehav Rev 6:247-96
15. Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ (1998) International Union of Pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50:291-314
16. Bastien CH, LeBlanc M, Carrier J, Morin CM (2003) Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines. Sleep 26:313-7
17. Belzung C, Le Guisquet AM, Griebel G (2000) Beta-CCT, a selective BZ-omega1 receptor antagonist, blocks the anti-anxiety but not the amnesic action of chlordiazepoxide in mice. Behav Pharmacol 11:125-31
18. Benavides J, Peny B, Dubois A, Perrault G, Morel E, Zivkovic B, Scatton B (1988) In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype. J Pharmacol Exp Ther 245:1033-41
19. Benavides J, Peny B, Ruano D, Vitorica J, Scatton B (1993) Comparative autoradiographic distribution of central ω (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem. Brain Res 604:240-250
20. Benca RM (2005) Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv (Washington, DC 56:332-43
21. Benington JH, Kodali SK, Heller HC (1994) Scoring transitions to REM sleep in rats based on the EEG phenomena of pre-REM sleep: an improved analysis of sleep structure. Sleep 17:28-36
22. Benson JA, Löw K, Keist R, Mohler H, Rudolph U (1998) Pharmacology of recombinant γ-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated α-subunits. FEBS Lett 431:400-404
23. Bergman J, Johanson C (1985) The reinforcing properties of diazepam under several conditions in the rhesus monkey. Psychopharmacology 86:108-113
24. Berlin I, Warot D, Hergueta T, Molinier P, Bagot C, Puech AJ (1993) Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol 13:100-6
25. Berridge KC, Peciña S (1995) Benzodiazepines, appetite, and taste palatability. Neurosci Biobehav Rev 19:121-131
26. Bettica P, Squassante L, Groeger JA, Gennery B, Winsky-Sommerer R, Dijk DJ (2012) Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia. Neuropsychopharmacology 37:1224-33
27. Blaschke G, Hempel G, Muller WE (1993) Preparative and analytical separation of the zopiclone enantiomers and determination of their affinity to the benzodiazepine receptor binding site. Chirality 5:419-21
28. Blednov YA, Jung S, Alva H, Wallace D, Rosahl T, Whiting P-J, Harris RA (2003) Deletion of the α1 or β2 subunit of GABAA receptors reduces actions of alcohol and other drugs. J Pharmacol Exp Ther 304:30-36
29. Borbely AA, Tobler I (1989) Endogenous sleep-promoting substances and sleep regulation. Physiol Rev 69:605-670
30. Borbely AA, Mattmann P, Loepfe M, Strauch I, Lehmann D (1985) Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum Neurobiol 4:189-94
31. Breimer DD, Jochemsen R (1983) Clinical pharmacokinetics of hypnotic benzodiazepines: a summary. Br J Clin Pharmacol 16(Suppl 2):277S-278S
32. Brooks SP, Dunnett SB (2009) Tests to assess motor phenotype in mice: a user's guide. Nat Rev Neurosci 10:519-29
33. Brunner DP, Dijk DJ, Munch M, Borbely AA (1991) Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacol (Berl) 104:1-5
34. Cabe PA, Tilson HA, Mitchell CL, Dennis R (1978) A simple recording grip strength device. Pharmacol Biochem Behav 8:101-2
35. Caldji C, Diorio J, Anisman H, Meaney MJ (2004) Maternal behavior regulates benzodiazepine/GABAA receptor subunit expression in brain regions associated with fear in BALB/c and C57BL/6 mice. Neuropsychopharmacology 29:1344-52
36. Carden SE, Coons EE (1990) Diazepam's impact on self-stimulation but not stimulation-escape suggests hedonic modulation. Behav Neurosci 104:56-61
37. Center for Behavioral Health Statistics and Quality (SAMHSA). Online (2013) Emergency department visits for adverse reactions involving the insomnia medication zolpidem. Available at http://www.samhsa.gov/data/2k13/DAWN079/sr079- Zolpidem.htm (Accessed 18 August 2013)
38. Chandra D, Korpi ER, Miralles CP, De Blas AL, Homanics GE (2005) GABAA receptor gamma 2 subunit knockdown mice have enhanced anxiety-like behavior but unaltered hypnotic response to benzodiazepines. BMC Neurosci 6:30
39. Chen H, Kuo T, Shaw F-Z, Lai C, Yang C (2005) Sleep-related vagotonic effect of zolpidem in rats. Psychopharmacol (Berl) 181:270-279
40. Cohen C, Sanger DJ (1994) Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps. Psychopharmacol (Berl) 115:86-94
41. Colpaert FC (1999) Drug discrimination in neurobiology. Pharmacol Biochem Behav 64:337-345
42. Cooper SJ (1980) Benzodiazepines as appetite-enhancing compounds. Appetite 1:7-19
43. Cooper SJ, Desa A (1988) Pyrazoloquinolines and zolpidem: effects on hypertonic saline consumption in rehydrating rats. Drug Dev Res 14:161-168
44. Cooper SJ, Higgs S (2005) Benzodiazepine effects on licking responses for sodium chloride solutions in water-deprived male rats. Physiol Behav 85:252-258
45. Cooper SJ, Yerbury RE (1988) Clonazepam selectively increases saccharin ingestion in a two-choice test. Brain Res 456:173-6
46. Cope DW, Wulff P, Oberto A, Aller MI, Capogna M, Ferraguti F, Halbsguth C, Hoeger H, Jolin HE, Jones A, McKenzie ANJ, Ogris W, Poeltl A, Sinkkonen ST, Vekovischeva OY, Korpi ER, Sieghart W, Sigel E, Somogyi P, Wisden W (2004) Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor γ2 subunit. Neuropharmacology 47:17-34
47. Crawley JN, Davis LG (1982) Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains. Brain Res Bull 8:609-12
48. Crawley J, Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167-70
49. Crestani F, Martin JR, Mohler H, Rudolph U (2000) Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 131:1251-1254
50. Crestani F, Löw K, Keist R, Mandelli M-J, Möhler H, Rudolph U (2001) Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 59:442-445
51. Cubala WJ, Landowski J (2007) Seizure following sudden zolpidem withdrawal. Prog Neuropsychopharm Biol Psychiatry 31:539-40
52. Cui XY, Zhao X, Chu QP, Chen BQ, Zhang YH (2007) Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test. J Neural Transm 114:155-60
53. Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 237:649-658
54. Depoortere H, Françon D, van Luijtelaar ELJM, Drinkenburg WHIM, Coenen AML (1995) Differential effects of midazolam and zolpidem on sleep-wake states and epileptic activity in WAG/Rij rats. Pharmacol Biochem Behav 51:571-576
55. Doane JA, Dalpiaz AS (2008) Zolpidem-induced sleep-driving. Am J Med 121:e5
56. Doghramji PP (2007) Insomnia: zolpidem extended-release for the treatment of sleep induction and sleep maintenance symptoms. MedGenMed 9:11
57. Drover DR (2004) Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clin Pharmacokinet 43:227-238
58. Duke A, Platt D, Cook J, Huang S, Yin W, Mattingly B, Rowlett J (2006) Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes. Psychopharmacol (Berl) 187:321-330
59. Duncan GE, Knapp DJ, Breese GR, Crews FT, Little KY (1998) Species differences in regional patterns of 3H-8-OH-DPAT and 3H-zolpidem binding in the rat and human brain. Pharmacol Biochem Behav 60:439-448
60. Durand A, Thenot JP, Bianchetti G, Morselli PL (1992) Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem. Drug Metab Rev 24:239-66
61. Ebert B, Anderson NJ, Cremers TI, Rasmussen S, Vogel V, Fahey JM, Sánchez C (2008) Gaboxadol - a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing. Pharmacol Biochem Behav 90:113-122
62. Edgar DM, Seidel WF, Gee KW, Lan NC, Field G, Xia H, Hawkinson JE, Wieland S, Carter RB, Wood PL (1997) CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat. J Pharmacol Exp Ther 282:420-9
63. Elliot EE, White JM (2000) Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem. Pharmacol Biochem Behav 66:361-369
64. Evans SM, Funderburk FR, Griffiths RR (1990) Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 255:1246-55
65. Fahey JM, Grassi JM, Reddi JM, Greenblatt DJ (2006) Acute zolpidem administration produces pharmacodynamic and receptor occupancy changes at similar doses. Pharmacol Biochem Behav 83:21-27
66. Fava M, Asnis GM, Shrivastava R, Lydiard B, Bastani B, Sheehan D, Roth T (2009) Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. J Clin Psychopharmacol 29:222-30
67. Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T (2011) Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. J Clin Psychiatry 72:914-28
68. Feinberg I, Maloney T, Campbell IG (2000) Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications. J Psychiatr Res 34:423-438
69. File SE (1981) Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats. Psychopharmacol (Berl) 73:240-5
70. File SE (1990) The history of benzodiazepine dependence: a review of animal studies. Neurosci Biobehav Rev 14:135-146
71. Fischer BD, Atack JR, Platt DM, Reynolds DS, Dawson GR, Rowlett JK (2011) Contribution of GABA(A) receptors containing alpha3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys. Psychopharmacol (Berl) 215:311-9
72. Fischer B, Teixeira L, Linn M, Namjoshi O, Cook J, Rowlett J (2013) Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation. Psychopharmacology 227:347-354
73. Foster AC, Pelleymounter MA, Cullen MJ, Lewis D, Joppa M, Chen TK, Bozigian HP, Gross RS, Gogas KR (2004) In vivo pharmacological characterization of indiplon, a novel pyrazolopyrimidine sedative-hypnotic. J Pharmacol Exp Ther 311:547-59
74. Fradley RL, Guscott MR, Bull S, Hallett DJ, Goodacre SC, Wafford KA, Garrett EM, Newman RJ, O'Meara GF, Whiting PJ, Rosahl TW, Dawson GR, Reynolds DS, Atack JR (2007) Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands. J Psychopharmacol 21:384-91
75. Fyer AJ, Liebowitz MR, Gorman JM, Campeas R, Levin A, Davies SO, Goetz D, Klein DF (1987) Discontinuation of alprazolam treatment in panic patients. Am J Psychiatry 144:303-8
76. Galpern WR, Lumpkin M, Greenblatt DJ, Shader RI, Miller LG (1991) Chronic benzodiazepine administration. VII. Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration. Psychopharmacol (Berl) 104:225-30
77. Garrett KM, Niekrasz I, Haque D, Parker KM, Seale TW (1998) Genotypic differences between C57BL/6 and A inbred mice in anxiolytic and sedative actions of diazepam. Behav Genet 28:125-36
78. Garrigou-Gadenne D, Burke JT, Durand A, Depoortere H, Thenot JP, Morselli PL (1989) Pharmacokinetics, brain distribution and pharmaco- electrocorticographic profile of zolpidem, a new hypnotic, in the rat. J Pharmacol Exp Ther 248:1283-8
79. Geller I, Seifter J (1960) The effects of meprobamate, barbiturates, D-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1:482-492
80. Gericke CA, Ludolph AC (1994) Chronic abuse of zolpidem. JAMA J Am Med Assoc 272:1721-2
81. Griebel G, Sanger DJ, Perrault G (1996) The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands. Psychopharmacol (Berl) 124:245-54
82. Griebel G, Perrault G, Sanger DJ (1998) Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents. J Psychopharmacol 12:356-65
83. Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H, Sanger DJ (1999) New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes. Psychopharmacol (Berl) 146:205-13
84. Griebel G, Belzung C, Perrault G, Sanger DJ (2000) Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacol (Berl) 148:164-170
85. Griffiths RR, Weerts EM (1997) Benzodiazepine self-administration in humans and laboratory animals - implications for problems of long-term use and abuse. Psychopharmacol (Berl) 134:1-37
86. Griffiths RR, Lamb RJ, Sannerud CA, Ator NA, Brady JV (1991) Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons. Psychopharmacol (Berl) 103:154-61
87. Griffiths RR, Sannerud CA, Ator NA, Brady JV (1992) Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. J Pharmacol Exp Ther 260:1199-1208
88. Gunther U, Benson J, Benke D, Fritschy J, Reyes G, Knoflach F, Crestani F, Aguzzi A, Arigoni M, Lang Y, Bluethmann H, Mohler H, Luscher B (1995) Benzodiazepine-insensitive mice generated by targeted disruption of the γ2 subunit gene of γ-aminobutyric acid type A receptors. Proc Natl Acad Sci 92:7749-7753
89. Hadingham KL, Garrett EM, Wafford KA, Bain C, Heavens RP, Sirinathsinghji DJ, Whiting PJ (1996) Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors. Mol Pharmacol 49:253-9
90. Hajak G, Hedner J, Eglin M, Loft H, Sí S, Lütolf S, Lundahl J (2009) A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients. Sleep Med 10:705-712
91. Hanson SM, Morlock EV, Satyshur KA, Czajkowski C (2008) Structural requirements for eszopiclone and zolpidem binding to the γ-aminobutyric acid type-A (GABAA) receptor are different. J Med Chem 51:7243-7252
92. Harrison NL (2007) Mechanisms of sleep induction by GABA(A) receptor agonists. J Clin Psychiatry 68(Suppl 5):6-12
93. Harvey S (1980) Hypnotics and sedatives. In: Gilman AGRT, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 339-375
94. Headlee CP, Coppock HW, Hichols JR (1955) Apparatus and technique involved in a laboratory method of detecting the addictiveness of drugs. J Am Pharm Assoc Am Pharm Assoc (Baltim) 44:229-31
95. Heikkinen AE, Moykkynen TP, Korpi ER (2009) Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists. Neuropsychopharmacology 34:290-8
96. Homanics GE, Harrison NL, Quinlan JJ, Krasowski MD, Rick CE, de Blas AL, Mehta AK, Kist F, Mihalek RM, Aul JJ, Firestone LL (1999a) Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the gamma2 subunit of the gamma-aminobutyrate type A receptor. Neuropharmacology 38:253-65
97. Homanics GE, Quinlan JJ, Firestone LL (1999b) Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines. Pharmacol Biochem Behav 63:21-26
98. Hoque R, Chesson AL Jr (2009) Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med 5:471-6
99. Huang MC, Lin HY, Chen CH (2007) Dependence on zolpidem. Psychiatry Clin Neurosci 61:207-8
100. Huang MP, Radadia K, Macone BW, Auerbach SH, Datta S (2010) Effects of eszopiclone and zolpidem on sleep-wake behavior, anxiety-like behavior and contextual memory in rats. Behav Brain Res 210:54-66
101. Izquierdo I, Medina JH (1991) GABAA receptor modulation of memory: the role of endogenous benzodiazepines. Trends Pharmacol Sci 12:260-5
102. Jensen RA, Martinez JL Jr, Vasquez BJ, McGaugh JL (1979) Benzodiazepines alter acquisition and retention of an inhibitory avoidance response in mice. Psychopharmacol (Berl) 64:125-6
103. Jones BJ, Roberts DJ (1968) The quantitative measurement of motor incoordination in naive mice using an accelerating rotarod. J Pharm Pharmacol 20:302-4
104. Khom S, Baburin I, Timin EN, Hohaus A, Sieghart W, Hering S (2006) Pharmacological properties of GABAA receptors containing γ1 subunits. Mol Pharmacol 69:640-649
105. Kilts CD, Commissaris RL, Rech RH (1981) Comparison of anti-conflict drug effects in three experimental animal models of anxiety. Psychopharmacol (Berl) 74:290-6
106. Kohut SJ, Ator NA (2008) Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023. Pharmacol Biochem Behav 90:65-73
107. Kopp C, Rudolph U, Keist R, Tobler I (2003) Diazepam-induced changes on sleep and the EEG spectrum in mice: role of the α3-GABAA receptor subtype. Eur J Neurosci 17:2226-2230
108. Kopp C, Rudolph U, Low K, Tobler I (2004a) Modulation of rhythmic brain activity by diazepam: GABA(A) receptor subtype and state specificity. Proc Natl Acad Sci U S A 101:3674-9
109. Kopp C, Rudolph U, Tobler I (2004b) Sleep EEG changes after zolpidem in mice. Neuroreport 15:2299-302
110. Kralic JE, Korpi ER, O'Buckley TK, Homanics GE, Morrow AL (2002a) Molecular and pharmacological characterization of GABAA receptor alpha 1 subunit knockout mice. J Pharmacol Exp Ther 302:1037-1045
111. Kralic JE, O'Buckley TK, Khisti RT, Hodge CW, Homanics GE, Morrow AL (2002b) GABAA receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem. Neuropharmacology 43:685-694
112. Kripke DF (2007) Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry 7:42
113. Kuruba R, Hattiangady B, Parihar VK, Shuai B, Shetty AK (2011) Differential susceptibility of interneurons expressing neuropeptide Y or parvalbumin in the aged hippocampus to acute seizure activity. PLoS ONE 6:e24493
114. Lader M (2011) Benzodiazepines revisited - will we ever learn? Addict (Abingdon, England) 106:2086-2109
115. Lancel M (1999) Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists. Sleep 22:33-42
116. Landolt HP, Finelli LA, Roth C, Buck A, Achermann P, Borbely AA (2000) Zolpidem and sleep deprivation: different effect on EEG power spectra. J Sleep Res 9:175-83
117. Langer SZ, Arbilla S, Benavides J, Scatton B (1990) Zolpidem and alpidem: two imidazopyridines with selectivity for omega 1- and omega 3-receptor subtypes. Adv Biochem Psychopharmacol 46:61-72
118. Lau CE, Sun L, Wang Q, Falk JL (2002) The effect of zolpidem on operant behavior and its relation to pharmacokinetics after intravenous and subcutaneous administration: concentration-effect relations. Behav Pharmacol 13:93-103
119. Le Moal M, Koob GF (2007) Drug addiction: pathways to the disease and pathophysiological perspectives. Eur Neuropsychopharmacol 17:377-93
120. Lelas S, Rowlett JK, Spealman RD (2001) Triazolam discrimination in squirrel monkeys distinguishes high-efficacy agonists from other benzodiazepines and non-benzodiazepine drugs. Psychopharmacol (Berl) 154:96-104
121. Lelas S, Rowlett JK, Spealman RD, Cook JM, Ma C, Li X, Yin W (2002) Role of GABAA/benzodiazepine receptors containing alpha 1 and alpha 5 subunits in the discriminative stimulus effects of triazolam in squirrel monkeys. Psychopharmacol (Berl) 161:180-8
122. Leufkens TRM, Lund JS, Vermeeren A (2009) Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. J Sleep Res 18:387-396
123. Licata SC, Rowlett JK (2008) Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond. Pharmacol Biochem Behav 90:74-89
124. Licata SC, Rowlett JK (2011) Self-administration of bretazenil under progressive-ratio schedules: behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepines. Drug Alcohol Depend 113:157-64
125. Licata SC, Penetar DM, Dunlap S, Lukas SE (2008) A therapeutic dose of zolpidem has limited abuse-like effects in drug-naïve females: a pilot study. Eur J Pharmacol 598:64-67
126. Licata SC, Platt DM, Cook JM, Van Linn ML, Rowlett JK (2009) Contribution of alpha1 subunit-containing gamma-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys. Psychopharmacol (Berl) 203:539-46
127. Licata SC, Platt DM, Ruedi-Bettschen D, Atack JR, Dawson GR, Van Linn ML, Cook JM, Rowlett JK (2010) Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy) - [1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes. Neuropharmacology 58:357-64
128. Licata SC, Mashhoon Y, Maclean RR, Lukas SE (2011) Modest abuse-related subjective effects of zolpidem in drug-naive volunteers. Behav Pharmacol 22:160-6
129. Linden A-M, Aller MI, Leppä E, Rosenberg PH, Wisden W, Korpi ER (2008) K+ channel TASK-1 knockout mice show enhanced sensitivities to ataxic and hypnotic effects of GABAA receptor ligands. J Pharmacol Exp Ther 327:277-286
130. Lobarinas E, Falk JL (2000) Comparison of benzodiazepines and the non-benzodiazepine agents zolpidem and zaleplon with respect to anxiolytic action as measured by increases in hypertonic NaCl-solution drinking in rats. Psychopharmacol (Berl) 149:176-180
131. Loscher W (2002) Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50:105-23
132. Loscher W (2011) Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 20:359-68
133. Loscher W, Frey HH (1977) Effect of convulsant and anticonvulsant agents on level and metabolism of gamma-aminobutyric acid in mouse brain. Naunyn Schmiedebergs Arch Pharmacol 296:263-9
134. Loscher W, Schmidt D (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2:145-181
135. Low K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Mohler H, Rudolph U (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131-4
136. Luddens H, Seeburg PH, Korpi ER (1994) Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors. Mol Pharmacol 45:810-4
137. Lukas SE, Griffiths RR (1984) Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. Eur J Pharmacol 100:163-71
138. Mailliet F, Galloux P, Poisson D (2001) Comparative effects of melatonin, zolpidem and diazepam on sleep, body temperature, blood pressure and heart rate measured by radiotelemetry in Wistar rats. Psychopharmacol (Berl) 156:417-426
139. Mathiasen LS, Mirza NR, Rodgers RJ (2008) Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice. Pharmacol Biochem Behav 90:19-36
140. Mattila MJ, Vanakoski J, Kalska H, Seppälä T (1998) Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. Pharmacol Biochem Behav 59:917-923
141. McKernan RM, Whiting PJ (1996) Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 19:139-143
142. McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers J, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, Brown N, Howell O, Moore KW, Carling RW, Street LJ, Castro JL, Ragan CI, Dawson GR, Whiting PJ (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor [alpha]1 subtype. Nat Neurosci 3:587-592
143. McMahon LR, Gerak LR, France CP (2001) Potency of positive gamma-aminobutyric acid(A) modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam-treated monkeys. J Pharmacol Exp Ther 298:1227-35
144. McMahon LR, Gerak LR, Carter L, Ma C, Cook JM, France CP (2002) Discriminative stimulus effects of benzodiazepine (BZ)(1) receptor-selective ligands in rhesus monkeys. J Pharmacol Exp Ther 300:505-12
145. Mehta AK, Ticku MK (1999) An update on GABAA receptors. Brain Res Brain Res Rev 29:196-217
146. Meririnne E, Kankaanpaa A, Lillsunde P, Seppala T (1999) The effects of diazepam and zolpidem on cocaine- and amphetamine-induced place preference. Pharmacol Biochem Behav 62:159-64
147. Metten P, Belknap JK, Crabbe JC (1998) Drug withdrawal convulsions and susceptibility to convulsants after short-term selective breeding for acute ethanol withdrawal. Behav Brain Res 95:113-122
148. Mikolajczak P, Okulicz-Kozaryn I, Szczawinska K, Kaminska E, Kus K (1999) Zolpidem involvement on memory and hypnotic effect of ethanol in chronically ethanol-treated rats. Alcohol Alcohol 34:511-9
149. Milic M, Divljakovic J, Rallapalli S, van Linn ML, Timic T, Cook JM, Savic MM (2012) The role of alpha1 and alpha5 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats. Behav Pharmacol 23:191-7
150. Millan MJ, Brocco M (2003) The Vogel conflict test: procedural aspects, γ-aminobutyric acid, glutamate and monoamines. Eur J Pharmacol 463:67-96
151. Miller LG, Woolverton S, Greenblatt DJ, Lopez F, Roy RB, Shader RI (1989) Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration. Biochem Pharmacol 38:3773-7
152. Mirza NR, Nielsen EØ (2006) Do subtype-selective γ-aminobutyric acidA receptor modulators have a reduced propensity to induce physical dependence in mice? J Pharmacol Exp Ther 316:1378-1385
153. Mirza NR, Rodgers RJ, Mathiasen LS (2006) Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination. J Pharmacol Exp Ther 316:1291-9
154. Mitchell CP, Ost ML, Flaherty CF (2004) Evidence for zolpidem-induced hyperphagia, but not anxiolysis, in a successive negative contrast paradigm. Pharmacol Biochem Behav 79:523-31
155. Mohler H, Fritschy JM, Rudolph U (2002) A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300:2-8
156. Monti JM (2004) Primary and secondary insomnia: prevalence, causes and current therapeutics. Curr Med Chem Cent Nerv Syst Agents 4:119-137
157. Morgan PT, Kehne JH, Sprenger KJ, Malison RT (2010) Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans. J Sleep Res 19:157-64
158. Morgenthaler TI, Silber MH (2002) Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med 3:323-7
159. Moy SS, Knapp DJ, Criswell HE, Breese GR (1997) Flumazenil blockade of anxiety following ethanol withdrawal in rats. Psychopharmacol (Berl) 131:354-60
160. Murphy HM, Ihekoronze C, Wideman CH (2011) Zolpidem-induced changes in
161. Nakajima T, Sasaki T, Nakagome K, Takazawa S, Ikebuchi E, Ito Y, Miyazawa Y, Tanaka M, Kanno O (2000) Comparison of the effects of zolpidem and zopiclone on nocturnal sleep and sleep latency in the morning: a cross-over study in healthy young volunteers. Life Sci 67:81-90
162. Nolan JP, Morley PT, Vanden Hoek TL, Hickey RW (2003) Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation 108:118-121
163. Ogris W, Poltl A, Hauer B, Ernst M, Oberto A, Wulff P, Hoger H, Wisden W, Sieghart W (2004) Affinity of various benzodiazepine site ligands in mice with a point mutation in the GABA(A) receptor gamma2 subunit. Biochem Pharmacol 68:1621-9
164. Ohl F, Sillaber I, Binder E, Keck ME, Holsboer F (2001) Differential analysis of behavior and diazepam-induced alterations in C57BL/6N and BALB/c mice using the modified hole board test. J Psychiatr Res 35:147-54
165. Olivier B, Bouwknecht JA, Pattij T, Leahy C, van Oorschot R, Zethof TJJ (2002) GABAA-benzodiazepine receptor complex ligands and stress-induced hyperthermia in singly housed mice. Pharmacol Biochem Behav 72:179-188
166. Olivier B, Zethof T, Pattij T, van Boogaert M, van Oorschot R, Leahy C, Oosting R, Bouwknecht A, Veening J, van der Gugten J, Groenink L (2003) Stress-induced hyperthermia and anxiety: pharmacological validation. Eur J Pharmacol 463:117-132
167. Otmani S, Demazières A, Staner C, Jacob N, Nir T, Zisapel N, Staner L (2008) Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol Clin Exp 23:693-705
168. Owen RT, Tyrer P (1983) Benzodiazepine dependence. Rev Evid Drugs 25:385-98
169. Paronis C, Cox E, Cook J, Bergman J (2001) Different types of GABAA receptors may mediate the anticonflict and response rate-decreasing effects of zaleplon, zolpidem, and midazolam in squirrel monkeys. Psychopharmacol (Berl) 156:461-468
170. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-67
171. Peričić D, Vlainić J, Štrac D (2008) Sedative and anticonvulsant effects of zolpidem in adult and aged mice. J Neural Transm 115:795-802
172. Perrault G, Morel E, Sanger DJ, Zivkovic B (1988) The interaction between zolpidem and beta-CMC: a clue to the identification of receptor sites involved in the sedative effect of zolpidem. Eur J Pharmacol 156:189-96
173. Perrault G, Morel E, Sanger DJ, Zivkovic B (1990) Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur J Pharmacol 187:487-94
174. Perrault G, Morel E, Sanger DJ, Zivkovic B (1992) Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J Pharmacol Exp Ther 263:298-303
175. Pick CG, Chernes Y, Rigai T, Rice KC, Schreiber S (2005) The antinociceptive effect of zolpidem and zopiclone in mice. Pharmacol Biochem Behav 81:417-423
176. Pieri L, Biry P (1985) Isoniazid-induced convulsions in rats: effects of Ro 15-1788 and beta-CCE. Eur J Pharmacol 112:355-62
177. Platt DM, Rowlett JK, Spealman RD, Cook J, Ma C (2002) Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys. Psychopharmacol (Berl) 164:151-9
178. Priest R, Terzano M, Parrino L, Boyer P (1997) Efficacy of zolpidem in insomnia. Eur Psychiatry 12(Suppl 1):5-14
179. Pritchett DB, Seeburg PH (1991) gamma-Aminobutyric acid type A receptor point mutation increases the affinity of compounds for the benzodiazepine site. Proc Natl Acad Sci U S A 88:1421-5
180. Pritchett DB, Luddens H, Seeburg PH (1989) Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. Science 245:1389-92
181. Puia G, Vicini S, Seeburg PH, Costa E (1991) Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents. Mol Pharmacol 39:691-696
182. Quinlan JJ, Firestone LL, Homanics GE (2000) Mice lacking the long splice variant of the γ2 subunit of the GABAA receptor are more sensitive to benzodiazepines. Pharmacol Biochem Behav 66:371-374
183. Renard S, Olivier A, Granger P, Avenet P, Graham D, Sevrin M, George P, Besnard F (1999) Structural elements of the γ-aminobutyric acid type A receptor conferring subtype selectivity for benzodiazepine site ligands. J Biol Chem 274:13370-13374
184. Renger JJ, Dunn SL, Motzel SL, Johnson C, Koblan KS (2004) Sub-chronic administration of zolpidem affects modifications to rat sleep architecture. Brain Res 1010:45-54
185. Reynolds LM, Engin E, Tantillo G, Lau HM, Muschamp JW, Carlezon WA Jr, Rudolph U (2012) Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward. Neuropsychopharmacology 37:2531-40
186. Robert C, Guilpin C, Limoge A (1999) Automated sleep staging systems in rats. J Neurosci Methods 88:111-122
187. Rode F, Jensen DG, Blackburn-Munro G, Bjerrum OJ (2005) Centrally-mediated antinociceptive actions of GABAA receptor agonists in the rat spared nerve injury model of neuropathic pain. Eur J Pharmacol 516:131-138
188. Roehrs T, Merlotti L, Zorick F, Roth T (1994) Sedative, memory, and performance effects of hypnotics. Psychopharmacol (Berl) 116:130-4
189. Rosenberg HC (1995) Differential expression of benzodiazepine anticonvulsant cross-tolerance according to time following flurazepam or diazepam treatment. Pharmacol Biochem Behav 51:363-8
190. Rosenberg RP (2006) Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies. Ann Clin Psychiatry 18:49-56
191. Rowlett JK, Lelas S (2007) Comparison of zolpidem and midazolam self-administration under progressive-ratio schedules: consumer demand and labor supply analyses. Exp Clin Psychopharmacol 15:328-37
192. Rowlett JK, Woolverton WL (1997) Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats. J Pharmacol Exp Ther 280:162-173
193. Rowlett JK, Spealman RD, Lelas S (1999) Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics. J Pharmacol Exp Ther 291:1233-1241
194. Rowlett JK, Lelas S, Spealman RD (2000) Transduction of the discriminative stimulus effects of zolpidem by GABA(A)/alpha1 receptors. Eur J Pharmacol 406:R9-R10
195. Rowlett JK, Spealman RD, Lelas S, Cook JM, Yin W (2003) Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors. Psychopharmacol (Berl) 165:209-15
196. Rowlett JK, Platt DM, Lelas S, Atack JR, Dawson GR (2005) Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci U S A 102:915-20
197. Rowlett JK, Kehne JH, Sprenger KJ, Maynard GD (2011) Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervals. Psychopharmacol (Berl) 214:855-62
198. Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, Mohler H (1999) Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401:796-800
199. Rush CR, Madakasira S, Goldman NH, Woolverton WL, Rowlett JK (1997) Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans. J Pharmacol Exp Ther 280:174-88
200. Rush CR, Baker RW, Wright K (1999) Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans. Psychopharmacol (Berl) 144:220-33
201. Rush CR, Baker RW, Rowlett JK (2000) Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans. Exp Clin Psychopharmacol 8:22-36
202. Sancar F, Ericksen SS, Kucken AM, Teissére JA, Czajkowski C (2007) Structural determinants for high-affinity zolpidem binding to GABA-A receptors. Mol Pharmacol 71:38-46
203. Sanger DJ (1987) Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines. Psychopharmacol (Berl) 93:365-8
204. Sanger DJ, Benavides J (1993) Discriminative stimulus effects of omega (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system. Psychopharmacol (Berl) 111:315-22
205. Sanger DJ, Depoortere H (1998) The pharmacology and mechanism of action of zolpidem. CNS Drug Reviews 4:323-340
206. Sanger DJ, Zivkovic B (1986) The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic. Psychopharmacol (Berl) 89:317-22
207. Sanger DJ, Zivkovic B (1987) Investigation of the development of tolerance to the actions of zolpidem and midazolam. Neuropharmacology 26:1513-8
208. Sanger DJ, Zivkovic B (1988) Further behavioural evidence for the selective sedative action of zolpidem. Neuropharmacology 27:1125-30
209. Sanger DJ, Zivkovic B (1992) Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors. Neuropharmacology 31:693-700
210. Sanger DJ, Zivkovic B (1994) Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic. Psychopharmacol (Berl) 113:395-403
211. Sanger DJ, Joly D, Zivkovic B (1986) Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice. Comparison with triazolam and CL 218,872. Psychopharmacol (Berl) 90:207-10
212. Sanger DJ, Morel E, Perrault G (1996) Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. Eur J Pharmacol 313:35-42
213. Sanger DJ, Griebel G, Perrault G, Claustre Y, Schoemaker H (1999) Discriminative stimulus effects of drugs acting at GABA(A) receptors: differential profiles and receptor selectivity. Pharmacol Biochem Behav 64:269-73
214. Sannerud CA, Ator NA (1995) Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists. J Pharmacol Exp Ther 275:183-93
215. Sansone RA, Sansone LA (2008) Zolpidem, somnambulism, and nocturnal eating. Gen Hosp Psychiatry 30:90-1
216. Savic MM, Obradovic DI, Ugresic ND, Cook JM, Yin W, Bokonjic DR (2004) Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt. Pharmacol Biochem Behav 79:279-90
217. Savic MM, Obradovic DI, Ugresic ND, Cook JM, Sarma PV, Bokonjic DR (2005a) Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt. Psychopharmacol (Berl) 180:455-65
218. Savic MM, Obradovic DI, Ugresic ND, Cook JM, Yin W, Bokonjic DR (2005b) Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt. Behav Brain Res 158:293-300
219. Savic MM, Milinkovic MM, Rallapalli S, Clayton T Sr, Joksimovic S, Van Linn M, Cook JM (2009) The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats. Int J Neuropsychopharmacol 12:1179-93
220. Schmid L, Bottlaender M, Fuseau C, Fournier D, Brouillet E, Maziere M (1995) Zolpidem displays heterogeneity in its binding to the nonhuman primate benzodiazepine receptor in vivo. J Neurochem 65:1880-6
221. Schmitt U, Hiemke C (1998) Combination of open field and elevated plus-maze: a suitable test battery to assess strain as well as treatment differences in rat behavior. Prog Neuro-Psychopharmacol Biol Psychiatry 22:1197-1215
222. Schmitt U, Lüddens H, Hiemke C (2000) Behavioral effects of GABAA receptor stimulation and GABA-transporter inhibition. Pharmacol Biochem Behav 65:351-356
223. Selleri S, Bruni F, Costagli C, Costanzo A, Guerrini G, Ciciani G, Gratteri P, Besnard F, Costa B, Montali M, Martini C, Fohlin J, De Siena G, Aiello PM (2005) A novel selective GABAA α1 receptor agonist displaying sedative and anxiolytic-like properties in rodents. J Med Chem 48:6756-6760
224. Semba K, Adachi N, Arai T (2005) Facilitation of serotonergic activity and amnesia in rats caused by intravenous anesthetics. Anesthesiology 102:616-23
225. Sethi PK, Khandelwal DC (2005) Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure. J Assoc Physicians India 53:139-40
226. Sieghart W, Fuchs K, Tretter V, Ebert V, Jechlinger M, Hoger H, Adamiker D (1999) Structure and subunit composition of GABAA receptors. Neurochem Int 34:379-385
227. Siemiatkowski M, Sienkiewicz-Jarosz H, CzŁonkowska AI, Bidziński A, PŁaźnik A (2000) Effects of buspirone, diazepam, and zolpidem on open field behavior, and brain [3H]muscimol binding after buspirone pretreatment. Pharmacol Biochem Behav 66:645-651
228. Sigel E (2002) Mapping of the benzodiazepine recognition site on GABA(A) receptors. Curr Top Med Chem 2:833-9
229. Silva RH, Frussa-Filho R (2000) The plus-maze discriminative avoidance task: a new model to study memory-anxiety interactions. Effects of chlordiazepoxide and caffeine. J Neurosci Methods 102:117-125
230. Smith GB, Olsen RW (1995) Functional domains of GABAA receptors. Trends Pharmacol Sci 16:162-168
231. Smith AJ, Alder L, Silk J, Adkins C, Fletcher AE, Scales T, Kerby J, Marshall G, Wafford KA, McKernan RM, Atack JR (2001) Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux. Mol Pharmacol 59:1108-18
232. Spyraki C, Kazandjian A, Varonos D (1985) Diazepam-induced place preference conditioning: appetitive and antiaversive properties. Psychopharmacol (Berl) 87:225-32
233. Stanhope KJ, Roe S, Dawson G, Draper F, Jackson A (1993) Effect of the benzodiazepine receptor agonist, zolpidem, on palatable fluid consumption in the rat. Psychopharmacol (Berl) 111:185-9
234. Steiner MA, Lecourt H, Strasser DS, Brisbare-Roch C, Jenck F (2011) Differential effects of the dual orexin receptor antagonist almorexant and the GABA(A)-alpha1 receptor modulator zolpidem, alone or combined with ethanol, on motor performance in the rat. Neuropsychopharmacology 36:848-56
235. Stoops WW, Rush CR (2003) Differential effects in humans after repeated administrations of zolpidem and triazolam. Am J Drug Alcohol Abuse 29:281-99
236. Straub CJ, Carlezon WA Jr, Rudolph U (2010) Diazepam and cocaine potentiate brain stimulation reward in C57BL/6J mice. Behav Brain Res 206:17-20
237. Sur C, Wafford KA, Reynolds DS, Hadingham KL, Bromidge F, Macaulay A, Collinson N, O'Meara G, Howell O, Newman R, Myers J, Atack JR, Dawson GR, McKernan RM, Whiting PJ, Rosahl TW (2001) Loss of the major GABAA receptor subtype in the brain is not lethal in mice. J Neurosci 21:3409-3418
238. Swainston Harrison T, Gillian MK (2005) Zolpidem: a review of its use in the management of insomnia. CNS Drugs 19:65-89
239. Tan KR, Brown M, Labouebe G, Yvon C, Creton C, Fritschy JM, Rudolph U, Luscher C (2010) Neural bases for addictive properties of benzodiazepines. Nature 463:769-74
240. Tan KR, Rudolph U, Luscher C (2011) Hooked on benzodiazepines: GABAA receptor subtypes and addiction. Trends Neurosci 34:188-97
241. Tanaka M, Suemaru K, Watanabe S, Cui R, Li B, Araki H (2008) Comparison of short- and long-acting benzodiazepine-receptor agonists with different receptor selectivity on motor coordination and muscle relaxation following thiopental-induced anesthesia in mice. J Pharmacol Sci 107:277-84
242. Tang AH, Smith MW, Carter DB, Im WB, VonVoigtlander PF (1995) U-90042, a sedative/hypnotic compound that interacts differentially with the GABAA receptor subtypes. J Pharmacol Exp Ther 275:761-7
243. Thiebot MH (1985) Some evidence for amnesic-like effects of benzodiazepines in animals. Neurosci Biobehav Rev 9:95-100
244. Tobler I, Kopp C, Deboer T, Rudolph U (2001) Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype. Proc Natl Acad Sci U S A 98:6464-9
245. Troy SM, Lucki I, Unruh MA, Cevallos WH, Leister CA, Martin PT, Furlan PM, Mangano R (2000) Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. J Clin Psychopharmacol 20:328-37
246. Tuk B, van Gool T, Danhof M (2002) Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol. J Pharmacokinet Pharmacodyn 29:235-50
247. Uchimura N, Nakajima T, Hayash K, Nose I, Hashizume Y, Ohyama T, Habukawa M, Kotorii N, Kuwahara H, Maeda H (2006) Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam. Prog Neuro-Psychopharmacol Biol Psychiatry 30:22-29
248. U.S. Department of Health and Human Services. Online. 2007. FDA requests label change for all sleep disorder drug products. Available at http://www.fda.gov/newsevents/newsroom/pressannouncements/2007/ucm108868.htm (Accessed 18 August 2013)
249. U.S. Department of Health and Human Services. Online. 2013. FDA Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem. Available at http://www.fda.gov/Drugs/DrugSafety/ucm334033.htm (Accessed 18 August 2013)
250. Van Bogaert M, Oosting R, Toth M, Groenink L, van Oorschot R, Olivier B (2006) Effects of genetic background and null mutation of 5-HT1A receptors on basal and stress-induced body temperature: modulation by serotonergic and GABAA-ergic drugs. Eur J Pharmacol 550:84-90
251. Van Der Heyden JAM, Zethof TJJ, Olivier B (1997) Stress-induced hyperthermia in singly housed mice. Physiol Behav 62:463-470
252. van Lier H, Drinkenburg WHIM, van Eeten YJW, Coenen AML (2004) Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats. Neuropharmacology 47:163-174
253. van Rijnsoever C, Tauber M, Choulli MK, Keist R, Rudolph U, Mohler H, Fritschy JM, Crestani F (2004) Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 24:6785-90
254. Vanover KE, Robledo S, Huber M, Carter RB (1999) Pharmacological evaluation of a modified conflict procedure: punished drinking in non-water-deprived rats. Psychopharmacol (Berl) 145:333-41
255. Vicini S, Ferguson C, Prybylowski K, Kralic J, Morrow AL, Homanics GE (2001) GABA(A) receptor alpha1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. J Neurosci 21:3009-16
256. Victorri-Vigneau C, Feuillet F, Wainstein L, Grall-Bronnec M, Pivette J, Chaslerie A, Sébille V, Jolliet P (2013) Pharmacoepidemiological characterisation of zolpidem and zopiclone usage. Eur J Clin Pharmacol 1-8
257. Vinkers CH, Olivier B (2012) Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABA(A) receptor modulators? Adv Pharmacol Sci 2012:416864
258. Vinkers CH, Klanker M, Groenink L, Korte SM, Cook JM, Van Linn ML, Hopkins SC, Olivier B (2009) Dissociating anxiolytic and sedative effects of GABAAergic drugs using temperature and locomotor responses to acute stress. Psychopharmacol (Berl) 204:299-311
259. Vinkers C, Oorschot R, Korte SM, Olivier B, Groenink L (2010) 5-HT1A receptor blockade reverses GABAA receptor α3 subunit-mediated anxiolytic effects on stress-induced hyperthermia. Psychopharmacol (Berl) 211:123-130
260. Vinkers CH, Olivier B, Hanania T, Min W, Schreiber R, Hopkins SC, Campbell U, Paterson N (2011) Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem. Eur J Pharmacol 668:190-193
261. Vinkers CH, van Oorschot R, Nielsen EO, Cook JM, Hansen HH, Groenink L, Olivier B, Mirza NR (2012) GABA(A) receptor alpha subunits differentially contribute to diazepam tolerance after chronic treatment. PLoS ONE 7:e43054
262. Vlainic J, Pericic D (2009) Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam. Neuropharmacology 56:1124-30
263. Vlainić J, Peričić D (2010) Zolpidem is a potent anticonvulsant in adult and aged mice. Brain Res 1310:181-188
264. A receptors expressed in HEK 293 cells. Naunyn Schmiedeberg's Arch Pharmacol 382:201-212
265. Vogel HG, Vogel WH (2002) Drug discovery and evaluation: pharmacological assays. Springer, New York
266. Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1-7
267. Von Moltke LL, Greenblatt DJ, Granda BW, Duan SX, Grassi JM, Venkatakrishnan K, Harmatz JS, Shader RI (1999) Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. Br J Clin Pharmacol 48:89-97
268. VonVoigtlander PF, Lewis RA (1991) A rapid screening method for the assessment of benzodiazepine receptor-related physical dependence in mice. Evaluation of benzodiazepine-related agonists and partial agonists. J Pharmacol Methods 26:1-5
269. Voss J, Sanchez C, Michelsen S, Ebert B (2003) Rotarod studies in the rat of the GABAA receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance. Eur J Pharmacol 482:215-22
270. Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ (1996) Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit. Mol Pharmacol 50:670-8
271. Walker MP, Brakefield T, Morgan A, Hobson JA, Stickgold R (2002) Practice with sleep makes perfect: sleep-dependent motor skill learning. Neuron 35:205-211
272. Walsh JK, Erman M, Erwin CW, Jamieson A, Mahowald M, Regestein Q, Scharf M, Tigel P, Vogel G, Ware JC (1998) Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia. Hum Psychopharmacol Clin Exp 13:191-198
273. Weerts EM, Griffiths RR (1998) Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Behav Pharmacol 9:285-97
274. Weerts EM, Ator NA, Grech DM, Griffiths RR (1998) Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. J Pharmacol Exp Ther 285:41-53
275. Weerts EM, Fantegrossi WE, Goodwin AK (2007) The value of nonhuman primates in drug abuse research. Exp Clin Psychopharmacol 15:309-27
276. Wieland HA, Lüddens H, Seeburg PH (1992) A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J Biol Chem 267:1426-1429
277. Wilkinson CJ (1998) The abuse potential of zolpidem administered alone and with alcohol. Pharmacol Biochem Behav 60:193-202
278. Wingrove PB, Thompson SA, Wafford KA, Whiting PJ (1997) Key amino acids in the gamma subunit of the gamma-aminobutyric acidA receptor that determine ligand binding and modulation at the benzodiazepine site. Mol Pharmacol 52:874-81
279. Wisden W, Herb A, Wieland H, Keinanen K, Luddens H, Seeburg PH (1991) Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor alpha 4 subunit. FEBS Lett 289:227-30
280. Witkin JM, Perez LA (1989) Comparison of effects of buspirone and gepirone with benzodiazepines and antagonists of dopamine and serotonin receptors on punished behavior of rats. Behav Pharmacol 1:247-254
281. Woods JH, Katz JL, Winger G (1987) Abuse liability of benzodiazepines. Pharmacol Rev 39:251-413
282. Wu Y, Rosenberg HC, Chiu TH, Ramsey-Williams V (1994) Regional changes in [3H]zolpidem binding to brain benzodiazepine receptors in flurazepam tolerant rat: comparison with changes in [3H]flunitrazepam binding. J Pharmacol Exp Ther 268:675-682
283. Wu Y, Rosenberg HC, Chiu TH (1995) Rapid down-regulation of [3H]zolpidem binding to rat brain benzodiazepine receptors during flurazepam treatment. Eur J Pharmacol 278:125-132
284. Xi M, Chase MH (2008) Effects of eszopiclone and zolpidem on sleep and waking states in the adult guinea pig. Sleep 31:1043-51
285. Yanagita T, Takahashi S (1973) Dependence liability of several sedative-hypnotic agents evaluated in monkeys. J Pharmacol Exp Ther 185:307-16
286. Yoshimoto M, Higuchi H, Kamata M, Yoshida K, Shimizu T, Hishikawa Y (1999) The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats. Eur Neuropsychopharmacol 9:29-35
287. Young R, Glennon RA (1987) Stimulus properties of benzodiazepines: correlations with binding affinities, therapeutic potency, and structure activity relationships (SAR). Psychopharmacol (Berl) 93:529-33
288. Zanin KA, CdL P, Tufik S, Poyares D, Frussa-Filho R (2011) Zolpidem impairs non-associative memory in mice. Sleep Sci 4:81-87
289. Zanin KA, Patti CL, Sanday L, Fernandes-Santos L, Oliveira LC, Poyares D, Tufik S, Frussa-Filho R (2013) Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task. Psychopharmacol (Berl) 226:459-74
290. Zeller A, Crestani F, Camenisch I, Iwasato T, Itohara S, Fritschy JM, Rudolph U (2008) Cortical glutamatergic neurons mediate the motor sedative action of diazepam. Mol Pharmacol 73:282-291